HC Wainwright Reaffirms Buy Rating for Palvella Therapeutics (NASDAQ:PVLA)
HC Wainwright restated their buy rating on shares of Palvella Therapeutics (NASDAQ:PVLA – Free Report) in a research report sent to investors on Wednesday,Benzinga reports. They currently have a $38.00 price target on the stock. Several other equities research analysts have also recently commented on the stock. TD Cowen initiated coverage on shares of Palvella […]
HC Wainwright restated their buy rating on shares of Palvella Therapeutics (NASDAQ:PVLA – Free Report) in a research report sent to investors on Wednesday,Benzinga reports. They currently have a $38.00 price target on the stock. Several other equities research analysts have also recently commented on the stock. TD Cowen initiated coverage on shares of Palvella […]
